These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 29876690)

  • 1. Differences in clinical Pneumocystis pneumonia in rheumatoid arthritis and other connective tissue diseases suggesting a rheumatoid-specific interstitial lung injury spectrum.
    Shimada K; Yokosuka K; Nunokawa T; Sugii S
    Clin Rheumatol; 2018 Aug; 37(8):2269-2274. PubMed ID: 29876690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and radiological features of Pneumocystis pneumonia in patients with rheumatoid arthritis, in comparison with methotrexate pneumonitis and Pneumocystis pneumonia in acquired immunodeficiency syndrome: a multicenter study.
    Tokuda H; Sakai F; Yamada H; Johkoh T; Imamura A; Dohi M; Hirakata M; Yamada T; Kamatani N; Kikuchi Y; Sugii S; Takeuchi T; Tateda K; Goto H
    Intern Med; 2008; 47(10):915-23. PubMed ID: 18480575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute exacerbation of interstitial pneumonia associated with rheumatoid arthritis during the course of treatment for Pneumocystis jirovecii pneumonia: a case report.
    Kuroda T; Takeuchi H; Nozawa Y; Sato H; Nakatsue T; Wada Y; Moriyama H; Nakano M; Narita I
    BMC Res Notes; 2016 Apr; 9():240. PubMed ID: 27113212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and radiological features of acute-onset diffuse interstitial lung diseases in patients with rheumatoid arthritis receiving treatment with biological agents: importance of Pneumocystis pneumonia in Japan revealed by a multicenter study.
    Kameda H; Tokuda H; Sakai F; Johkoh T; Mori S; Yoshida Y; Takayanagi N; Taki H; Hasegawa Y; Hatta K; Yamanaka H; Dohi M; Hashimoto S; Yamada H; Kawai S; Takeuchi T; Tateda K; Goto H
    Intern Med; 2011; 50(4):305-13. PubMed ID: 21325762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of pneumocystis pneumonia complicated in patients with rheumatoid arthritis (RA) and non-RA rheumatic diseases.
    Yoshida Y; Takahashi Y; Minemura N; Ueda Y; Yamashita H; Kaneko H; Mimori A
    Mod Rheumatol; 2012 Aug; 22(4):509-14. PubMed ID: 21971942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pneumocystis pneumonia developed in two patients with rheumatoid arthritis during treatment of adalimumab].
    Ikeuchi H; Umemoto A; Tsukida M; Sakurai N; Maeshima A; Kuroiwa T; Hiromura K; Nojima Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(5):420-5. PubMed ID: 22041430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes and risk factors for mortality in Pneumocystis pneumonia patients with rheumatoid arthritis: A multicentre retrospective cohort study.
    Mori S; Ueki Y; Miyamura T; Ishii K; Hidaka T; Yoshitama T; Nakamura K; Suenaga Y
    Mod Rheumatol; 2023 Jul; 33(4):723-731. PubMed ID: 35920411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Soluble Interleukin-2 Receptor Is a Biomarker for Pneumocystis jirovecii Pneumonia among Patients with Rheumatoid Arthritis under Methotrexate Therapy.
    Sakamoto N; Hara S; Ishimoto H; Nakashima S; Yura H; Miyamura T; Okuno D; Hara A; Kakugawa T; Yamaguchi H; Obase Y; Kushima H; Ishii H; Noguchi S; Kido T; Kobayashi T; Soejima Y; Yoshioka S; Ishimatsu Y; Yatera K; Kadota JI; Mukae H
    Tohoku J Exp Med; 2019 Jul; 248(3):209-216. PubMed ID: 31366819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Pneumocystis pneumonia infection risk factors in patients with connective tissue disease.
    Iikuni N; Kitahama M; Ohta S; Okamoto H; Kamatani N; Nishinarita M
    Mod Rheumatol; 2006; 16(5):282-8. PubMed ID: 17039308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Associated with Pneumocystis jirovecii Pneumonia in Patients with Rheumatoid Arthritis Receiving Methotrexate: A Single-center Retrospective Study.
    Ohmura SI; Homma Y; Masui T; Miyamoto T
    Intern Med; 2022 Apr; 61(7):997-1006. PubMed ID: 34511571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymptomatic carriage of Pneumocystis jiroveci in elderly patients with rheumatoid arthritis in Japan: a possible association between colonization and development of Pneumocystis jiroveci pneumonia during low-dose MTX therapy.
    Mori S; Cho I; Ichiyasu H; Sugimoto M
    Mod Rheumatol; 2008; 18(3):240-6. PubMed ID: 18306977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A followup study of asymptomatic carriers of Pneumocystis jiroveci during immunosuppressive therapy for rheumatoid arthritis.
    Mori S; Cho I; Sugimoto M
    J Rheumatol; 2009 Aug; 36(8):1600-5. PubMed ID: 19531759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pneumocystis carinii pneumonia associated with low dose methotrexate treatment for malignant rheumatoid arthritis].
    Okuda Y; Oyama T; Oyama H; Miyamoto T; Takasugi K
    Ryumachi; 1995 Aug; 35(4):699-704. PubMed ID: 7482069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pneumocystis jiroveci pneumonia as a complication of glucocorticoid therapy for interstitial pneumonia].
    Enomoto T; Azuma A; Matsumoto A; Nei T; Hiramatsu K; Abe S; Usuki J; Kudoh S
    Nihon Kokyuki Gakkai Zasshi; 2005 Dec; 43(12):725-30. PubMed ID: 16457333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality.
    Ward MM; Donald F
    Arthritis Rheum; 1999 Apr; 42(4):780-9. PubMed ID: 10211894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and risk factors for Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis receiving adalimumab: a retrospective review and case-control study of 17 patients.
    Watanabe K; Sakai R; Koike R; Sakai F; Sugiyama H; Tanaka M; Komano Y; Akiyama Y; Mimura T; Kaneko M; Tokuda H; Iso T; Motegi M; Ikeda K; Nakajima H; Taki H; Kubota T; Kodama H; Sugii S; Kuroiwa T; Nawata Y; Shiozawa K; Ogata A; Sawada S; Matsukawa Y; Okazaki T; Mukai M; Iwahashi M; Saito K; Tanaka Y; Nanki T; Miyasaka N; Harigai M
    Mod Rheumatol; 2013 Nov; 23(6):1085-93. PubMed ID: 23212592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study of pneumocystis pneumonia in patients with rheumatoid arthritis].
    Miyahara Y; Takayanagi N; Ishiguro T; Yoneda K; Tokunaga D; Aoki F; Kurashima K; Yanagisawa T; Sugita Y
    Nihon Kokyuki Gakkai Zasshi; 2011 Jan; 49(1):3-9. PubMed ID: 21384675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts.
    Kiely P; Busby AD; Nikiphorou E; Sullivan K; Walsh DA; Creamer P; Dixey J; Young A
    BMJ Open; 2019 May; 9(5):e028466. PubMed ID: 31061059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Clinical Characteristics of Pneumocystis Pneumonia between Patients with Rheumatoid Arthritis Being Treated with Biologics and Those Being Treated without Biologics.
    Akiyama M; Kaneko Y; Takeuchi T
    Biomed Res Int; 2017; 2017():3710652. PubMed ID: 28785579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumocystis carinii pneumonia in patients with connective tissue disease.
    Li J; Huang XM; Fang WG; Zeng XJ
    J Clin Rheumatol; 2006 Jun; 12(3):114-7. PubMed ID: 16755237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.